Zein nanoparticles as emerging moderators of the gut microbiome: Mechanisms, biomedical potentials and translational challenges
Source abstract
Abstract
Zein, a hydrophobic prolamin protein derived from maize, has emerged as a sustainable material for oral nanocarrier design due to its biodegradability, biocompatibility, and spontaneous self-assembly into stable NPs. This review critically examines the synthesis strategies, physicochemical behavior, and biological performance of zein NPs (ZNPs) with particular emphasis on gastrointestinal delivery and microbiome-associated outcomes. Current evidence indicates that ZNPs act primarily as protective and transport matrices: their intrinsic properties govern gastric resistance, mucus interaction, and controlled intestinal release, thereby improving stability and bioavailability of encapsulated compounds. The review insights into the microbiome pathway within a carrier-enabled exposure framework to correlate the attributing causality by ZNPs in the frame of the reported alterations in microbial composition, metabolite production, and host physiology arising from delivered bioactive (e.g., drugs, polyphenols, or probiotics). Moreover, the study details the advances in fabrication approaches, including desolvation, electrospraying, flash nanoprecipitation, and microfluidic micromixing, which have improved particle uniformity and scalability, supporting applications in pharmaceutical and nutraceutical delivery. Several studies demonstrate enhanced intestinal targeting, prolonged residence time, and reduced systemic toxicity in inflammatory and metabolic disease models. However, translation remains limited by incomplete mechanistic mapping of carrier-cargo-microbiome interactions, a lack of standardized large-scale manufacturing protocols, and insufficient long-term safety assessment under repeated oral exposure. Future progress will require integrating empty-carrier controls, longitudinal microbiome analyses, harmonized production standards, and nano-specific regulatory evaluation frameworks. Establishing these criteria will enable rational design of zein-based systems as controlled oral delivery platforms rather than assuming intrinsic microbiome-modulating activity.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Gut microbiota and health · Nanoparticles: synthesis and applications · Cancer Research and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Gut microbiome–brain alliance: a landscape view into mental and gastrointestinal health and disorders10.1021/acschemneuro.3c00127 ↗
2. The gut microbiome: what the oncologist ought to know10.1038/s41416-021-01467-x ↗
3. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases10.3390/microorganisms7010014 ↗
4. Gut commensals and their metabolites in health and disease10.3389/fmicb.2023.1244293 ↗
5. Pathogen colonization resistance in the gut and its manipulation for improved health10.1016/j.ajpath.2019.03.003 ↗
6. Interaction between microbiota and immunity in health and disease10.1038/s41422-020-0332-7 ↗
7. Emerging paradigms in inflammatory disease management: exploring bioactive compounds and the gut microbiota10.3390/brainsci13081226 ↗
8. Selective nanoparticulate systems for drug delivery in inflammatory bowel disease10.3390/pharmaceutics18010055 ↗
9. Chitosan on the surface of nanoparticles for enhanced drug delivery: a comprehensive review10.1016/j.jconrel.2022.10.005 ↗
10. New zein protein composites with high performance in phosphate removal, intrinsic antibacterial, and drug delivery capabilities10.1021/acsami.4c04718 ↗
11. Zein as a versatile biopolymer: different shapes for different biomedical applications10.1039/D1RA07424E ↗
12. Advances and prospects of prolamine corn protein zein as promising multifunctional drug delivery system for cancer treatment10.2147/IJN.S402891 ↗
13. Application of enzymes as a feed additive in aquaculture, mar
14. Oral nanoparticulate drug delivery systems for the treatment of intestinal bowel disease and colorectal cancer10.1080/17425247.2023.2289586 ↗
15. Very low ileal nitrogen and amino acid digestibility of zein compared to whey protein isolate in healthy volunteers10.1093/ajcn/nqaa274 ↗
16. Characterization and refinement of zein-based gels10.1016/j.foodhyd.2019.105555 ↗
17. Zein nanoparticles as nontoxic delivery system for maytansine in the treatment of non-small cell lung cancer10.1080/10717544.2019.1704942 ↗
18. Recent advances in the application of zein-based gels: a review10.1016/j.eurpolymj.2022.111557 ↗
19. Microencapsulation: coacervation phase separation
20. Interfacial and emulsion-stabilizing properties of zein nanoparticles: differences among zein fractions (α-, β-, and γ-zein)10.1039/D0FO02536D ↗
21. Study on self-assembled morphology and structure regulation of α-Zein in ethanol–water mixtures10.1021/acs.langmuir.0c02143 ↗
22. Zein-based nanoparticles: preparation, characterization, and pharmaceutical application
23. Production and characterization of composite films with zein nanoparticles based on the complexity of continuous film matrix10.1016/j.lwt.2022.113396 ↗
24. Production and processing of zein nanoparticles as structural colorants10.1039/D5RA03113C ↗
25. Nanoparticles obtained from zein for encapsulation of mesalazine10.3390/pharmaceutics14122830 ↗
26. Advances in chitosan-based nanoparticles for drug delivery10.3390/ijms22179652 ↗
27. Zein and soy polysaccharide encapsulation enhances probiotic viability and modulates gut microbiota10.1016/j.lwt.2024.116827 ↗
28. Atomic force microscopy for cross‐disciplinary materials research10.1002/smtd.202500514 ↗
29. Zein-based nanoparticles as oral carriers for insulin delivery10.3390/pharmaceutics14010039 ↗
30. Tailored zein-polysaccharide nanoparticles for anthocyanin encapsulation: insights into preparation and characterization10.1016/j.foodhyd.2025.111365 ↗
31. Zein microparticles and nanoparticles as drug delivery systems10.3390/polym14112172 ↗
32. Zein-based nano-delivery systems for encapsulation and protection of hydrophobic bioactives: a review10.3389/fnut.2022.999373 ↗
33. Self-assembly mechanisms of zein induced by solvent evaporation: insights from morphological and structural evolution of micelles
34. The use of zein in the controlled release of poorly water-soluble drugs10.1016/j.ijpharm.2019.06.018 ↗
35. A new design for obtaining of white zein micro- and nanoparticles powder: antisolvent-dialysis method10.1007/s10068-019-00702-9 ↗
36. Zein-based nanoparticles as active platforms for sustainable applications: recent advances and perspectives10.3390/nano14050414 ↗
37. Encapsulation of enzymes in food industry using spray drying: recent advances and process scale-ups10.1080/10408398.2023.2193982 ↗
38. Supercritical antisolvent process for pharmaceutical applications: a review10.3390/pr8080938 ↗
39. Drug–zein@lipid hybrid nanoparticles: electrospraying preparation and drug extended release application10.1016/j.colsurfb.2021.111629 ↗
40. Application of flash nanoprecipitation to fabricate poorly water-soluble drug nanoparticles10.1016/j.apsb.2018.11.001 ↗
41. Microfluidic mixing and devices for preparing nanoparticulate drug delivery systems
42. Zein nanoparticles for drug delivery: preparation methods and biological applications10.1016/j.ijpharm.2023.122754 ↗
43. Development of curcumin loaded core–shell zein microparticles stabilized by cellulose nanocrystals and whey protein microgels through interparticle interactions10.1039/D1FO00959A ↗
44. Insulin- and cholic acid-loaded zein/casein–dextran nanoparticles enhance the oral absorption and hypoglycemic effect of insulin10.1039/D1TB00806D ↗
45. Preparation and evaluation of lecithin/zein hybrid nanoparticles for the oral delivery of Panax notoginseng saponins10.1016/j.ejps.2021.105882 ↗
46. Formation, structural characterization, stability and in vitro bioaccessibility of 7,8-dihydroxyflavone loaded zein-/sophorolipid composite nanoparticles: effect of sophorolipid under two blending sequences10.1039/C9FO02704A ↗
47. Chitosan-coated zein nanoparticles for oral delivery of resveratrol: formation, characterization, stability, mucoadhesive properties and antioxidant activity10.1016/j.foodhyd.2019.03.042 ↗
48. Alginate/chitosan-coated zein nanoparticles for the delivery of resveratrol10.1016/j.jfoodeng.2019.04.010 ↗
49. Fabrication, characterization, and antimicrobial activity of carvacrol-loaded zein nanoparticles using the pH-Driven method10.3390/ijms23169227 ↗
50. pH-driven self-assembly of alcohol-free curcumin-loaded zein-propylene glycol alginate complex nanoparticles10.1016/j.ijbiomac.2022.06.046 ↗
51. Entrapment of curcumin in whey protein isolate and zein composite nanoparticles using pH-driven method10.1016/j.foodhyd.2020.105839 ↗
52. Preparation and characterisation of curcumin‐loaded pea protein‐zein nanocomplexes using pH‐driven method10.1111/ijfs.15683 ↗
53. Surface coating of zein nanoparticles to improve the application of bioactive compounds: a review10.1016/j.tifs.2021.12.025 ↗
54. Ultrasonic synthesis of nanochitosan and its size effects on turbidity removal and dealkalization in wastewater treatment10.3390/inventions6040098 ↗
55. Spray drying for the encapsulation of oils—A review10.3390/molecules25173873 ↗
56. Encapsulation of bioactive compounds using competitive emerging techniques: electrospraying, nano spray drying, and electrostatic spray drying10.1016/j.jfoodeng.2022.111260 ↗
57. A brief review of the supercritical antisolvent (SAS) technique for the preparation of nanocatalysts to be used in biodiesel production10.3390/en15249355 ↗
58. Solubility, extraction, and nanoparticles production in supercritical carbon dioxide: a mini‐review10.1002/cben.202200020 ↗
59. Preparation of zein nanoparticles by using solution-enhanced dispersion with supercritical CO2 and elucidation with computational fluid dynamics10.2147/IJN.S135239 ↗
60. Applications of supercritical anti-solvent process in preparation of solid multicomponent systems10.3390/pharmaceutics13040475 ↗
61. Electrosprayed nanoparticles as drug delivery systems for biomedical applications10.2174/1381612827666210929114621 ↗
62. Micro- and nano-encapsulation of β-carotene in zein protein: size-dependent release and absorption behavior10.1039/C9FO02088H ↗
63. Rational fabrication of folate-conjugated zein/soy lecithin/carboxymethyl chitosan core–shell nanoparticles for delivery of docetaxel10.1021/acsomega.2c01270 ↗
64. Fabrication of resveratrol-loaded zein nanoparticles based on flash nanoprecipitation10.1016/j.colsurfa.2022.129829 ↗
65. Using a microfluidics system to reproducibly synthesize protein nanoparticles: factors contributing to size, homogeneity, and stability10.3390/pr7050290 ↗
66. Fabrication of zein-modified starch nanoparticle complexes via microfluidic chip and encapsulation of nisin10.1016/j.crfs.2022.07.005 ↗
67. Hydrogel nanoparticles in drug delivery: a review, intell
68. Microfluidic instruments for nanoparticle synthesis, biomed
69. Microfluidics for personalized drug delivery10.1016/j.drudis.2024.103936 ↗
70. Controlling microencapsulation and release of micronized proteins using poly(ethylene glycol) and electrospraying10.1016/j.ejpb.2014.03.008 ↗
71. Recent developments in protein-based hydrogels for advanced drug delivery applications10.3390/pharmaceutics18010074 ↗
72. Scale-up of pharmaceutical spray drying using scale-up rules: a review10.1016/j.ijpharm.2019.03.047 ↗
73. Comparison of the effects of fasting glucose, hemoglobin A1c, and triglyceride–glucose index on cardiovascular events in type 2 diabetes mellitus10.3390/nu11112838 ↗
74. The gut microbiota–insulin resistance axis: mechanisms, clinical implications, and therapeutic potential10.1096/fba.2025-00218 ↗
75. In vitro digestion and intestinal absorption of curcumin-loaded zein nanoparticles10.1016/j.jff.2023.105818 ↗
76. Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity10.1016/j.immuni.2022.01.006 ↗
77. Roles and mechanisms of choline metabolism in nonalcoholic fatty liver disease and cancers10.31083/j.fbl2905182 ↗
78. Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota10.3390/nu15092211 ↗
79. The short-chain fatty acid acetate in body weight control and insulin sensitivity10.3390/nu11081943 ↗
80. Short-chain fatty acids—A product of the microbiome and its participation in two-way communication on the microbiome-host mammal line10.1007/s13679-023-00503-6 ↗
81. Lipogenesis inhibitors: therapeutic opportunities and challenges10.1038/s41573-021-00367-2 ↗
82. Rethinking short-chain fatty acids: a closer look at propionate in inflammation, metabolism, and mucosal homeostasis10.3390/cells14151130 ↗
83. A comprehensive review on microbial production of 1,2-propanediol: micro-organisms, metabolic pathways, and metabolic engineering10.1186/s13068-021-02067-w ↗
84. Short-chain fatty acids and human health: from metabolic pathways to current therapeutic implications10.3390/life14050559 ↗
85. Advancements in the study of short-chain fatty acids and their therapeutic effects on atherosclerosis10.1016/j.lfs.2025.123528 ↗
86. The propionate-GPR41 axis in infancy protects from subsequent bronchial asthma onset10.1080/19490976.2023.2206507 ↗
87. Butyryl/Caproyl-CoA:Acetate CoA-transferase: cloning, expression and characterization of the key enzyme involved in medium-chain fatty acid biosynthesis10.1042/BSR20211135 ↗
88. Butyrate's role in human health and the current progress towards its clinical application to treat gastrointestinal disease10.1016/j.clnu.2022.10.024 ↗
89. Amino acid catabolism: an overlooked area of metabolism10.3390/nu15153378 ↗
90. Butyrate to combat obesity and obesity‐associated metabolic disorders: current status and future implications for therapeutic use10.1111/obr.13498 ↗
91. Microbial short chain fatty acids: effective histone deacetylase inhibitors in immune regulation
92. The immunomodulatory functions of butyrate10.2147/JIR.S300989 ↗
93. Gut microbiome and plasma metabolome changes in rats after oral gavage of nanoparticles: sensitive indicators of possible adverse health effects10.1186/s12989-022-00459-w ↗
94. A systematic review on the effects of nanomaterials on gut microbiota
95. Recent progress of oral functional nanomaterials for intestinal microbiota regulation10.3390/pharmaceutics16070921 ↗
96. Gold nanoparticles exhibit anti-osteoarthritic effects via modulating interaction of the “microbiota-gut-joint” axis10.1186/s12951-024-02447-y ↗
97. A review of the evidence for tryptophan and the kynurenine pathway as a regulator of stem cell niches in health and disease10.1177/11786469241248287 ↗
98. The uniqueness of tryptophan in biology: properties, metabolism, interactions and localization in proteins10.3390/ijms21228776 ↗
99. Indoleamine dioxygenase and tryptophan dioxygenase activities are regulated through control of cell heme allocation by nitric oxide10.1016/j.jbc.2023.104753 ↗
100. Indoleamine 2,3‐dioxygenase 1 (IDO1): an up‐to‐date overview of an eclectic immunoregulatory enzyme10.1111/febs.16086 ↗